SBC Medical Launches “SBC Wellness 2.0” to Lead the Future of Performance Medicine and Longevity Care
SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a management services organization that partners with a wide network of franchised medical businesses, has announced the launch of its next-generation wellness platform, “SBC Wellness 2.0.” This innovative initiative represents a strategic move by the company to establish itself as a global leader in the rapidly evolving longevity and performance medicine market.
With the global longevity sector projected to grow dramatically—from approximately $800 billion by 2025 to nearly $2 trillion by 2035—SBC Medical is positioning itself at the forefront of this transformation. The market is expected to maintain a compound annual growth rate (CAGR) exceeding 10% between 2026 and 2035, signaling strong demand for advanced healthcare solutions that go beyond traditional disease treatment and focus instead on prevention, optimization, and extended quality of life.
A Strategic Expansion Beyond Aesthetic Medicine
SBC Medical has built a strong foundation in Japan’s aesthetic medicine market, which is currently valued at around $4 billion. Leveraging this expertise, the company is now expanding into the longevity space—an adjacent but still emerging market in Japan, estimated at approximately $34 billion. Despite its size, the Japanese longevity sector remains fragmented, with no clear dominant player, creating a unique opportunity for SBC Medical to establish leadership.
The introduction of SBC Wellness 2.0 marks a natural evolution of the company’s mission. Historically, SBC Medical has focused on helping individuals enhance their external appearance through aesthetic treatments. However, the company recognized a growing overlap between aesthetic concerns and overall health awareness. Individuals seeking to maintain a youthful appearance are increasingly attentive to their internal health and physical performance. This insight has driven SBC Medical to create a more comprehensive, integrated approach to wellness.
Yoshiyuki Aikawa, CEO of SBC Medical, emphasized this shift, noting that the company aims to help individuals reach their full potential not only in terms of appearance but also physical capability and long-term health. He highlighted the company’s ambition to first transform the Japanese longevity market before expanding its model internationally.
Introducing Performance Medicine
At the core of SBC Wellness 2.0 is the concept of “performance medicine,” a new category that combines elements of aesthetic care, preventive medicine, and advanced health analytics. Unlike traditional healthcare systems that primarily focus on diagnosing and treating illnesses, performance medicine emphasizes proactive health management, early detection, and continuous optimization of the human body.
SBC Wellness 2.0 is designed to prioritize prevention, physical performance, and holistic well-being. The platform integrates multiple advanced technologies and methodologies, including:
- Blood biomarker analysis to assess internal health indicators
- Medical imaging for deeper physiological insights
- Artificial intelligence (AI) to analyze data and generate personalized health recommendations
Through this approach, each client receives a comprehensive evaluation of their current health status, including insights into biological age, potential risks, and performance gaps.
A Personalized, Data-Driven Health Journey
The SBC Wellness 2.0 program follows a structured yet personalized journey designed to deliver measurable and sustainable outcomes. The process typically includes:
- Measurement and Data Collection
Clients undergo detailed assessments using biomarkers, imaging, and other diagnostic tools to establish a baseline. - Visualization and Insights
The collected data is translated into clear, actionable insights, including biological age and health risk indicators. - Customized Health Plan
Based on these insights, clients receive tailored recommendations that may include medical treatments, nutritional supplementation, and lifestyle modifications. - Digital Coaching and Monitoring
Ongoing support is provided through digital platforms, ensuring adherence to the plan and continuous engagement. - Progress Tracking and Optimization
Regular follow-ups allow for adjustments and improvements, ensuring long-term effectiveness.
This integrated model bridges the gap between external appearance and internal health, creating a unified approach that aligns aesthetic goals with physical optimization.
Competitive Advantages and Data-Driven Innovation
One of SBC Medical’s key strengths lies in its extensive operational scale and data capabilities. The company currently operates a network of 283 clinics and serves approximately 6.5 million client visits annually. This vast ecosystem generates one of the largest datasets in Japan’s aesthetic medicine sector.
This data serves as a critical asset in developing proprietary AI models, enabling SBC Medical to deliver highly personalized and predictive healthcare solutions. The company believes this capability creates significant barriers to entry for competitors, as the effectiveness of AI-driven healthcare solutions depends heavily on the volume and quality of available data.
In addition, SBC Medical is working toward building a comprehensive medical platform that integrates both aesthetic treatments and services covered by health insurance. This dual approach allows the company to address a broader spectrum of healthcare needs while maintaining a premium service offering.
Another distinguishing factor is the company’s expertise in luxury hospitality and user experience (UX) design. Through its management of high-end clinics, SBC Medical has developed a deep understanding of the expectations of premium clientele. This focus on customer experience enhances patient satisfaction and strengthens long-term relationships.
A Hybrid Revenue Model for Sustainable Growth
SBC Wellness 2.0 is supported by a diversified and scalable revenue model designed to generate recurring income while minimizing marketing costs. The company plans to offer its services through two primary channels:
- B2B Corporate Programs
Businesses can provide SBC Wellness 2.0 as an employee benefit, positioning it as an investment in workforce health, productivity, and retention. - Direct-to-Consumer Services
Individuals can access premium medical and aesthetic services on a pay-per-use or subscription basis.
This hybrid approach allows SBC Medical to tap into both corporate and individual markets. For corporate clients, the program offers a compelling value proposition by improving employee well-being, enhancing recruitment efforts, and reducing turnover. For SBC Medical, corporate partnerships provide a steady stream of clients and lower customer acquisition costs.
Management believes that the combination of subscription-based contracts and on-demand services will create a stable and predictable revenue stream while supporting long-term profitability.
As the global healthcare landscape continues to shift toward prevention and personalized care, SBC Medical’s entry into performance medicine positions it as a forward-thinking innovator. By integrating advanced technology, large-scale data, and a premium service model, the company aims to redefine how individuals approach health, aging, and overall well-being.
While the company acknowledges that forward-looking statements involve risks and uncertainties—including changes in economic, regulatory, and market conditions—it remains confident in its strategic direction and growth potential.
With SBC Wellness 2.0, SBC Medical is not only expanding its business but also contributing to a broader transformation in healthcare—one that prioritizes longevity, performance, and quality of life on a global scale.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a management services company that operates a wide range of franchised businesses in various medical fields, including advanced aesthetic care, dermatology, orthopedics, infertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The company manages a diversified portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the company was listed on the Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad-based benchmark of the U.S. stock market. Guided by its group’s mission, “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, reliable, and high-quality medical services, while further strengthening its international reputation for quality and trust in medical care.
